FdaApplication
ANDA 205017
Identifiers
- fda_app_no: ANDA205017
Properties
| Property | Value |
|---|---|
| applicant_name | NUVO PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2014-09-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 37.5MG | CAPSULE;ORAL |
1 product